Global Choroidal Neovascularization Market

1. Summary

The Global Choroidal Neovascularization Market was valued at $8.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.2% CAGR, to an estimated market size of $11.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global choroidal neovascularization (CNV) market includes the pharmaceutical therapies, diagnostic imaging, and surgical interventions used to treat the abnormal growth of blood vessels in the choroid layer of the eye. The scope primarily covers treatments for neovascular age-related macular degeneration (nAMD), pathologic myopia, and ocular histoplasmosis, while excluding general ophthalmic care not related to sub-retinal vascular leakage.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Choroidal Neovascularization Market in the period 2025-30:

• The global increase in the geriatric population remains the primary driver as age is the leading risk factor for wet age-related macular degeneration.
• There is a significant shift toward long-acting anti-VEGF agents and sustained-release delivery systems to reduce the high treatment burden of frequent intravitreal injections.
• The emergence of gene therapies designed for one-time administration is expected to disrupt the market by providing durable, long-term suppression of vascular leakage.
• Advancements in optical coherence tomography (OCT) and AI-driven diagnostic imaging are enabling earlier detection and more precise monitoring of retinal abnormalities.
• The increasing adoption of biosimilars for established anti-VEGF drugs is improving treatment affordability while intensifying competition among major pharmaceutical players.
• Rising prevalence of lifestyle-related diseases such as diabetes and hypertension is contributing to a higher incidence of secondary retinal vascular disorders.
• Market growth in emerging economies is accelerating due to improved healthcare infrastructure and expanded government initiatives for vision preservation.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: